603931.SH
格林达
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 34.95
−1.83%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 611.5M | 625.8M | 656.0M | 695.3M | 847.6M |
| Cost of Revenue | 414.9M | 428.6M | 423.7M | 435.3M | 591.4M |
| Gross Profit | 196.5M | 197.2M | 232.4M | 260.0M | 256.2M |
| Operating Expenses | |||||
| R&D Expense | 31.8M | 32.0M | 33.3M | 31.5M | 38.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 32.9M | 32.2M | 35.4M | 32.6M | 27.2M |
| Selling & Marketing Expense | 10.1M | 10.1M | 11.1M | 12.7M | 14.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 80.3M | 77.5M | 71.7M | 66.7M | 70.2M |
| Cost and Expenses | 495.2M | 506.1M | 495.4M | 502.1M | 661.6M |
| Operating Income (EBIT) | 136.7M | 140.2M | 168.6M | 201.8M | 185.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 136.8M | 140.4M | 168.6M | 202.0M | 185.9M |
| Income Tax Expense | 16.8M | 17.9M | 22.3M | 26.9M | 22.5M |
| Bottom Line | |||||
| Net Income | 120.0M | 122.5M | 146.2M | 175.1M | 163.4M |
| Earnings from Cont. Ops | 120.0M | 122.5M | 146.3M | 175.1M | 163.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 120.0M | 122.5M | 146.2M | 175.1M | 163.4M |
| Per Share | |||||
| Basic EPS | CN¥0.60 | CN¥0.61 | CN¥0.73 | CN¥0.88 | CN¥0.82 |
| Diluted EPS | CN¥0.60 | — | — | — | — |
| Revenue Per Share | CN¥3.13 | CN¥3.12 | CN¥3.27 | CN¥3.50 | CN¥4.25 |
| Shares | |||||
| Basic Shares Outstanding | 195.4M | 200.8M | 200.3M | 198.9M | 199.3M |
| Diluted Shares Outstanding | 195.4M | 200.8M | 200.3M | 198.9M | 199.3M |
| Profitability Metrics | |||||
| EBITDA | — | 192.0M | 218.4M | 231.1M | 207.2M |
| D&A | — | 51.7M | 49.8M | 29.3M | 21.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026